Hirooka Y. Sympathetic activation in hypertension: importance of the central nervous system. Am J Hypertens. 2020;33:914–26.
Article CAS PubMed Google Scholar
Grassi G, Mancia G, Esler M. Central and peripheral sympathetic activation in heart failure. Cardiovasc Res. 2022;118:1857–71.
Article CAS PubMed Google Scholar
Shivkumar K, Ajijola OA, Anand I, Armour JA, Chen PS, Esler M, et al. Clinical neurocardiology defining the value of neuroscience-based cardiovascular therapeutics. J Physiol. 2016;594:3911–54.
Article CAS PubMed PubMed Central Google Scholar
Brandt MC, Mahfoud F, Reda S, Schirmer SH, Erdmann E, Böhm M, et al. Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension. J Am Coll Cardiol. 2012;59:901–9.
Mahfoud F, Urban D, Teller D, Linz D, Stawowy P, Hassel JH, et al. Effect of renal denervation on left ventricular mass and function in patients with resistant hypertension: data from a multi-centre cardiovascular magnetic resonance imaging trial. Eur Heart J. 2014;35:2224–31b.
Tahir E, Koops A, Warncke ML, Starekova J, Neumann JT, Waldeyer C, et al. Effect of renal denervation procedure on left ventricular mass, myocardial strain and diastolic function by CMR on a 12-month follow-up. Jpn J Radio. 2019;37:642–50.
Heradien M, Mahfoud F, Greyling C, Lauder L, van der Bijl P, Hettrick DA, et al. Renal denervation prevents subclinical atrial fibrillation in patients with hypertensive heart disease: randomized, sham-controlled trial. Heart Rhythm. 2022. https://doi.org/10.1016/j.hrthm.2022.06.031.
Watanabe H, Iwanaga Y, Miyaji Y, Yamamoto H, Miyazaki S. Renal denervation mitigates cardiac remodeling and renal damage in Dahl rats: a comparison with beta-receptor blockade. Hypertens Res. 2016;39:217–26.
Article CAS PubMed Google Scholar
Heradien M, Mahfoud F, Greyling C, Lauder L, van der Bijl P, Hettrick DA, et al. Renal denervation prevents subclinical atrial fibrillation in patients with hypertensive heart disease: randomized, sham-controlled trial. Heart Rhythm. 2022;19:1765–73.
Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med. 1991;114:345–52.
Article CAS PubMed Google Scholar
Pierdomenico SD, Cuccurullo F. Risk reduction after regression of echocardiographic left ventricular hypertrophy in hypertension: a meta-analysis. Am J Hypertens. 2010;23:876–81.
Kordalis A, Tsiachris D, Pietri P, Tsioufis C, Stefanadis C. Regression of organ damage following renal denervation in resistant hypertension: a meta-analysis. J Hypertens. 2018;36:1614–21.
Article CAS PubMed Google Scholar
Wang S, Yang S, Zhao X, Shi J. Effects of renal denervation on cardiac structural and functional abnormalities in patients with resistant hypertension or diastolic dysfunction. Sci Rep. 2018;8:1172.
Article PubMed PubMed Central Google Scholar
Xie L, Li Y, Luo S, Huang B Impact of renal denervation on cardiac remodeling in resistant hypertension: a meta‐analysis. Clin Cardiol. 2024;47:e24222.
Bazoukis G, Thomopoulos C, Tse G, Vassiliou VS, Liu T, Dimitriadis K, et al. Impact of renal sympathetic denervation on cardiac magnetic resonance-derived cardiac indices in hypertensive patients—a meta-analysis. J Cardiol. 2021;78:314–21.
Schlaich MP, Kaye DM, Lambert E, Sommerville M, Socratous F, Esler MD. Relation between cardiac sympathetic activity and hypertensive left ventricular hypertrophy. Circulation. 2003;108:560–5.
Tsoporis J, Leenen FH. Effects of arterial vasodilators on cardiac hypertrophy and sympathetic activity in rats. Hypertension. 1988;11:376–86.
Article CAS PubMed Google Scholar
Shinohara K, Kishi T, Hirooka Y, Sunagawa K. Circulating angiotensin II deteriorates left ventricular function with sympathoexcitation via brain angiotensin II receptor. Physiol Rep. 2015;3:e12514.
Article PubMed PubMed Central Google Scholar
Shibata R, Shinohara K, Ikeda S, Iyonaga T, Matsuura T, Kashihara S, et al. Transient receptor potential vanilloid 1-expressing cardiac afferent nerves may contribute to cardiac hypertrophy in accompany with an increased expression of brain-derived neurotrophic factor within nucleus tractus solitarius in a pressure overload model. Clin Exp Hypertens. 2022;44:249–57.
Article CAS PubMed Google Scholar
Wachtell K, Smith G, Gerdts E, Dahlöf B, Nieminen MS, Papademetriou V, et al. Left ventricular filling patterns in patients with systemic hypertension and left ventricular hypertrophy (the LIFE study). Am J Cardiol. 2000;85:466–72.
Article CAS PubMed Google Scholar
Benjamin EJ, Levy D, Vaziri SM, D’Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. Jama. 1994;271:840–4.
Article CAS PubMed Google Scholar
de Vos CB, Pisters R, Nieuwlaat R, Prins MH, Tieleman RG, Coelen RJ, et al. Progression from paroxysmal to persistent atrial fibrillation clinical correlates and prognosis. J Am Coll Cardiol. 2010;55:725–31.
Hanna P, Buch E, Stavrakis S, Meyer C, Tompkins JD, Ardell JL, et al. Neuroscientific therapies for atrial fibrillation. Cardiovasc Res. 2021;117:1732–45.
Article CAS PubMed PubMed Central Google Scholar
Nawar K, Mohammad A, Johns EJ, Abdulla MH. Renal denervation for atrial fibrillation: a comprehensive updated systematic review and meta-analysis. J Hum Hypertens. 2023;37:89–90.
Steinberg JS, Shabanov V, Ponomarev D, Losik D, Ivanickiy E, Kropotkin E, et al. Effect of renal denervation and catheter ablation vs catheter ablation alone on atrial fibrillation recurrence among patients with paroxysmal atrial fibrillation and hypertension: The ERADICATE-AF randomized clinical trial. JAMA. 2020;323:248–55.
Article PubMed PubMed Central Google Scholar
Kagawa Y, Fujii E, Fujita S, Ito M. Association between left atrial reverse remodeling and maintenance of sinus rhythm after catheter ablation of persistent atrial fibrillation. Heart Vessels. 2020;35:239–45.
Rettmann ME, Holmes DR 3rd, Monahan KH, Breen JF, Bahnson TD, Mark DB, et al. Treatment-related changes in left atrial structure in atrial fibrillation: findings from the CABANA imaging substudy. Circ Arrhythm Electrophysiol. 2021;14:e008540.
Article CAS PubMed PubMed Central Google Scholar
Osborn JW, Tyshynsky R, Vulchanova L. Function of renal nerves in kidney physiology and pathophysiology. Annu Rev Physiol. 2021;83:429–50.
Article CAS PubMed Google Scholar
Katsurada K, Shinohara K, Aoki J, Nanto S, Kario K. Renal denervation: basic and clinical evidence. Hypertens Res. 2022;45:198–209.
Katsuki M, Shinohara K, Kinugawa S, Hirooka Y. The effects of renal denervation on blood pressure, cardiac hypertrophy, and sympathetic activity during the established phase of hypertension in spontaneously hypertensive rats. Hypertens Res. 2024. https://doi.org/10.1038/s41440-024-01596-9.
Lauar MR, Evans LC, Van Helden D, Fink GD, Banek CT, Menani JV, et al. Renal and hypothalamic inflammation in renovascular hypertension: role of afferent renal nerves. Am J Physiol Regul Integr Comp Physiol. 2023;325:R411–22.
Article CAS PubMed Google Scholar
Wu L-L, Zhang Y, Li X-Z, Du X-L, Gao Y, Wang J-X, et al. Impact of selective renal afferent denervation on oxidative stress and vascular remodeling in spontaneously hypertensive rats. Antioxidants. 2022;11:1003.
Article CAS PubMed PubMed Central Google Scholar
Asirvatham-Jeyaraj N, Gauthier MM, Banek CT, Ramesh A, Garver H, Fink GD, et al. Renal denervation and celiac ganglionectomy decrease mean arterial pressure similarly in genetically hypertensive schlager (BPH/2J) mice. Hypertension. 2021;77:519–28.
留言 (0)